1. Home
  2. BNL vs AMRX Comparison

BNL vs AMRX Comparison

Compare BNL & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNL
  • AMRX
  • Stock Information
  • Founded
  • BNL 2007
  • AMRX 2002
  • Country
  • BNL United States
  • AMRX United States
  • Employees
  • BNL N/A
  • AMRX N/A
  • Industry
  • BNL Real Estate Investment Trusts
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BNL Real Estate
  • AMRX Health Care
  • Exchange
  • BNL Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • BNL 3.0B
  • AMRX 2.4B
  • IPO Year
  • BNL 2020
  • AMRX N/A
  • Fundamental
  • Price
  • BNL $15.93
  • AMRX $7.42
  • Analyst Decision
  • BNL Hold
  • AMRX Strong Buy
  • Analyst Count
  • BNL 6
  • AMRX 5
  • Target Price
  • BNL $18.60
  • AMRX $10.80
  • AVG Volume (30 Days)
  • BNL 1.6M
  • AMRX 1.9M
  • Earning Date
  • BNL 04-30-2025
  • AMRX 05-02-2025
  • Dividend Yield
  • BNL 7.25%
  • AMRX N/A
  • EPS Growth
  • BNL 3.57
  • AMRX N/A
  • EPS
  • BNL 0.86
  • AMRX N/A
  • Revenue
  • BNL $431,800,000.00
  • AMRX $2,793,957,000.00
  • Revenue This Year
  • BNL $5.31
  • AMRX $10.49
  • Revenue Next Year
  • BNL $4.57
  • AMRX $7.00
  • P/E Ratio
  • BNL $18.64
  • AMRX N/A
  • Revenue Growth
  • BNL N/A
  • AMRX 16.73
  • 52 Week Low
  • BNL $13.96
  • AMRX $5.18
  • 52 Week High
  • BNL $19.15
  • AMRX $9.48
  • Technical
  • Relative Strength Index (RSI)
  • BNL 47.02
  • AMRX 44.55
  • Support Level
  • BNL $15.73
  • AMRX $7.01
  • Resistance Level
  • BNL $16.36
  • AMRX $7.41
  • Average True Range (ATR)
  • BNL 0.62
  • AMRX 0.36
  • MACD
  • BNL 0.05
  • AMRX 0.03
  • Stochastic Oscillator
  • BNL 74.63
  • AMRX 75.38

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: